{
  "ptid_time": "032_S_4823_2015-07-06",
  "img_path": "/data/qiuhui/data/adni/images/032_S_4823/2015-07-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 79,291 mm³, 68.6% above the reference mean. With a Z-score of 1.99 (97.7th percentile), this represents moderate enlargement; hippocampal volume measures 5,107 mm³, 26.7% below the reference mean. With a Z-score of -2.31 (1.1th percentile), this represents significant atrophy; whole brain volume measures 897,952 mm³, 12.7% below the reference mean. With a Z-score of -1.67 (4.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 85.2 years. Gender is Male. Education: 18 years. MMSE: 26.0. MoCA: 21.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.58 SUVR (profound elevated); Amyloid beta: 1146.00 pg/mL (normal ); Total tau: 373.00 pg/mL (moderate elevated); Phosphorylated tau: 35.80 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal atrophy (Z-score -2.31) and moderate whole-brain atrophy (Z-score -1.67), along with ventricular enlargement (Z-score 1.99), which are structural changes commonly seen in neurodegenerative diseases. The cognitive scores (MMSE 26, MoCA 21) suggest mild cognitive impairment, while the biomarker profile (normal Aβ, elevated T-tau/P-tau, and profound AV45 uptake) indicates tau pathology and neurodegeneration, consistent with Alzheimer’s disease despite the absence of APOE4.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T05:06:40.941382"
}